Cancer Incidence Trends From 1999 to 2015 And Contributions Of Various Cancer Types To The Overall Burden: Projections To 2030 And Extrapolation Of Economic Burden In Saudi Arabia

References

• Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151–1210. doi:10.1016/S0140-6736(17)32152-928919116
   PubMed Web of Science ®Google Scholar
• Institute for Health Metrics and Evaluation (IHME). The Global Burden of Disease Study 2017. Institute for Health Metrics and Evaluation, Seattle, WA; 2018.
   Google Scholar
• World Health Organization. Report on the regional meeting on cancer control and research priorities Doha, Qatar 20–22 October 2013. 2013.
   Google Scholar
• Gulf Centre for Cancer Registration. Cancer Incidence Report: Gulf Cooperation Council Countries. Riyadh, Saudi Arabia:GCCR; 2014.
   Google Scholar
• Ministry of Health. Cancer Incidence Report Saudi Arabia 2014. Ministry of Health, Riyadh; 2014.
   Google Scholar
• Alwan A. Global Status Report on Noncommunicable Diseases 2010. World Health Organization; 2011.
   Google Scholar
• Alshammari FD, Ahmed HG, Alshammari D, Alharbi AM, Alsaedi AS, Elasbaly A. Population insight of the relationship between lifestyle and cancer: a population-based survey. AIMS Public Health. 2019;6:34. doi:10.3934/publichealth.2019.1.3430931341
   PubMed Web of Science ®Google Scholar
• Jazieh AR, AlGhamdi M, AlGhanem S, et al. Saudi lung cancer prevention and screening guidelines. Ann Thorac Med. 2018;13:198. doi:10.4103/atm.ATM_147_1830416590
   PubMedGoogle Scholar
• Van Houtven G, Honeycutt AA, Gilman B, McCall NT, Throneburg WW, Sykes KE Costs of illness among older adults: an analysis of six major health conditions with significant environmental risk factors. Research Triangle Park (NC): RTI Press; 2008.
   Google Scholar
• Beyene TJ, Mourits MCM, Kidane AH, Hogeveen H. Estimating the burden of rabies in Ethiopia by tracing dog bite victims. PLoS One. 2018;13:e0192313. doi:10.1371/journal.pone.019231329466403
   PubMed Web of Science ®Google Scholar
• Bojke L, Manca A, Asaria M, Mahon R, Ren S, Palmer S. How to appropriately extrapolate costs and utilities in cost-effectiveness analysis. Pharmacoeconomics. 2017;35:767–776. doi:10.1007/s40273-017-0512-628470594
   PubMed Web of Science ®Google Scholar
• Schreyer P, Koechlin F. Purchasing power parities 1999 benchmark results. Organization for Economic Co-operation and Development. 2002 Available from: http://www oecd org/pdf/M00028000/M00028875 pdf Accesssed 111, 2019.
   Google Scholar
• Triplett JE. Integrating Cost-Of-Disease Studies into Purchasing Power Parities. A Disease-Based Comparison of Health Systems. OECD, Paris, 2003:131.
   Google Scholar
• Huber M. International Comparisons of Prices and Volumes in Health Care among OECD Countries. Austria: European Center for Social Welfare Policy and Research; 2006.
   Google Scholar
• Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study. Lancet Oncol. 2012;13:790–801. doi:10.1016/S1470-2045(12)70211-522658655
   PubMed Web of Science ®Google Scholar
• Quante AS, Ming C, Rottmann M, et al. Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030. Cancer Med. 2016;5:2649–2656. doi:10.1002/cam4.76727356493
   PubMed Web of Science ®Google Scholar
• Mistry M, Parkin DM, Ahmad AS, Sasieni P. Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer. 2011;105:1795–1803. doi:10.1038/bjc.2011.43022033277
   PubMed Web of Science ®Google Scholar
• Ibrahim E, Bin Sadiq BM, Banjar L, Awadalla S, Abomelha MS. Current and future cancer burden in Saudi Arabia: meeting the challenge. Hematol Oncol Stem Cell Ther. 2008;1:210–215. doi:10.1016/S1658-3876(08)50006-920058475
   PubMedGoogle Scholar
• Althubiti MA, Nour Eldein MM. Trends in the incidence and mortality of cancer in Saudi Arabia. Saudi Med J. 2018;39:1259–1262. doi:10.15537/smj.2018.12.2334830520511
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Roser M, Ritchie H. Cancer. 2019 Published online at OurWorldInData.org Retrieved from: https://ourworldindata.org/cancer Accesssed 111, 2019 [Online Resource].
   Google Scholar
• Kushi LH, Byers T, Doyle C, et al. American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2006;56:254–281. quiz 313–4. doi:10.3322/canjclin.56.5.25417005596
   PubMed Web of Science ®Google Scholar
• Bishehsari F, Mahdavinia M, Vacca M, Malekzadeh R, Mariani-Costantini R. Epidemiological transition of colorectal cancer in developing countries: environmental factors, molecular pathways, and opportunities for prevention. World J Gastroenterol. 2014;20:6055. doi:10.3748/wjg.v20.i20.605524876728
   PubMed Web of Science ®Google Scholar
• Fitzmaurice C, Akinyemiju TF, Al Lami FH, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the global burden of disease study. JAMA Oncol. 2018;4:1553–1568. doi:10.1001/jamaoncol.2018.270629860482
   PubMed Web of Science ®Google Scholar
• Alsanea N, Abduljabbar AS, Alhomoud S, Ashari LH, Hibbert D, Bazarbashi S. Colorectal cancer in Saudi Arabia: incidence, survival, demographics and implications for national policies. Ann Saudi Med. 2015;35:196–202. doi:10.5144/0256-4947.2015.19626409793
   PubMed Web of Science ®Google Scholar
• Sengmany K, Singh J, Stewart GD, Conn PJ, Christopoulos A, Gregory KJ. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: implications for optimizing preclinical neuroscience drug discovery. Neuropharmacology. 2017;115:60–72. doi:10.1016/j.neuropharm.2016.07.00127392634
   PubMed Web of Science ®Google Scholar
• Menyhárt O, Fekete JT, Győrffy B. Demographic shift disproportionately increases cancer burden in an aging nation: current and expected incidence and mortality in Hungary up to 2030. Clin Epidemiol. 2018;10:1093. doi:10.2147/CLEP.S15506330214314
   PubMed Web of Science ®Google Scholar
• Coyle YM. Cancer epidemiology In: Lifestyle, Genes, and Cancer. Methods Mol Biol.2009; 472:25–56.
   Google Scholar
• Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev. 2011;20:2006–2014. doi:10.1158/1055-9965.EPI-11-065021980008
   PubMed Web of Science ®Google Scholar
• Mariotto AB, Robin Yabroff K, Shao Y, Feuer EJ, Brown ML. Projections of the cost of cancer care in the United States: 2010–2020. J Natl Cancer Inst. 2011;103:117–128. doi:10.1093/jnci/djq49521228314
   PubMed Web of Science ®Google Scholar
• Voda AI, Bostan I. Public health care financing and the costs of cancer care: a cross-national analysis. Cancers. 2018;10:117. doi:10.3390/cancers10040117
   PubMed Web of Science ®Google Scholar
• Cox C. How much does the US Spend to Treat Different Diseases. Peterson-Kaiser Health System Tracker, 2017.
   Google Scholar